cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
Authors
Keywords
-
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 393, Issue 2, Pages 287-302
Publisher
Springer Science and Business Media LLC
Online
2019-12-18
DOI
10.1007/s00210-019-01779-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled Study
- (2019) Robert J. Charnigo et al. CTS-Clinical and Translational Science
- Phosphatidic acid governs natural egress in Toxoplasma gondii via a guanylate cyclase receptor platform
- (2019) Hugo Bisio et al. Nature Microbiology
- Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease
- (2019) Lutz Frölich et al. Alzheimers Research & Therapy
- Pre-synaptic sympathetic calcium channels, cyclic nucleotide-coupled phosphodiesterases and cardiac excitability
- (2019) Dan Li et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- cGMP modulation therapeutics for sickle cell disease
- (2019) Nicola Conran et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Rationale and Design of the VITALITY-HFpEF Trial
- (2019) Javed Butler et al. Circulation-Heart Failure
- New dimensions in the field of antimalarial research against malaria resurgence
- (2019) Anudeep K. Narula et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structures of the cGMP-dependent protein kinase in malaria parasites reveal a unique structural relay mechanism for activation
- (2019) Majida El Bakkouri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mind the gap [junction]: NO‐induced cGMP in cardiac myocytes originates from fibroblasts
- (2019) Lukas Menges et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structural insights into the mechanism of human soluble guanylate cyclase
- (2019) Yunlu Kang et al. NATURE
- Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
- (2019) George S. Baillie et al. NATURE REVIEWS DRUG DISCOVERY
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Instability in a coiled‐coil signaling helix is conserved for signal transduction in soluble guanylyl cyclase
- (2019) Andrzej Weichsel et al. PROTEIN SCIENCE
- Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy
- (2019) Benjamin G Horst et al. eLife
- Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
- (2019) John F. Harms et al. Frontiers in Neuroscience
- Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
- (2019) Steven D Nathan et al. Lancet Respiratory Medicine
- New Insights into Malaria Pathogenesis
- (2019) Christopher A. Moxon et al. Annual Review of Pathology-Mechanisms of Disease
- Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan
- (2019) Richard T. Clements et al. Circulation-Heart Failure
- Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators
- (2018) Alexandru-Emil Matei et al. ANNALS OF THE RHEUMATIC DISEASES
- A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology
- (2018) Franz Hofmann BASIC RESEARCH IN CARDIOLOGY
- Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase
- (2018) Sandra Frankenreiter et al. CARDIOVASCULAR RESEARCH
- Malaria
- (2018) Elizabeth A Ashley et al. LANCET
- Nitric oxide signalling in cardiovascular health and disease
- (2018) Charlotte Farah et al. Nature Reviews Cardiology
- Redox regulation of soluble guanylyl cyclase
- (2018) Rohan C. Shah et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets
- (2018) Stephanie Makhoul et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- NO-GC in cells 'off the beaten track'
- (2018) Andreas Friebe et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Physiological activation and deactivation of soluble guanylate cyclase
- (2018) Benjamin G. Horst et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Structure/function of the soluble guanylyl cyclase catalytic domain
- (2018) Kenneth C. Childers et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential
- (2018) E.S. Buys et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Genetic alterations in the NO-cGMP pathway and cardiovascular risk
- (2018) Jana Wobst et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure
- (2018) Reshma S. Baliga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
- (2018) David Brown et al. SCHIZOPHRENIA BULLETIN
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator
- (2018) Paul W. Armstrong et al. JACC-Heart Failure
- Oxidation of cysteine 117 stimulates constitutive activation of the type Iα cGMP-dependent protein kinase
- (2018) Jessica L Sheehe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GC-B Deficient Mice With Axon Bifurcation Loss Exhibit Compromised Auditory Processing
- (2018) Steffen Wolter et al. Frontiers in Neural Circuits
- Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery
- (2018) Michael A. Hollas et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle
- (2018) Jordan E. Balke et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
- (2017) Burkert Pieske et al. EUROPEAN HEART JOURNAL
- Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
- (2017) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase
- (2017) Jessica A. Wales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intravascular hemolysis and the pathophysiology of sickle cell disease
- (2017) Gregory J. Kato et al. JOURNAL OF CLINICAL INVESTIGATION
- Meeting report of the 8th International Conference on cGMP “cGMP: generators, effectors, and therapeutic implications” at Bamberg, Germany, from June 23 to 25, 2017
- (2017) Andreas Friebe et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
- (2017) Peter Sandner et al. RESPIRATORY MEDICINE
- RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosis
- (2017) Oliver Distler et al. RESPIRATORY MEDICINE
- A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
- (2017) David A. Baker et al. Nature Communications
- Cyclic nucleotide signalling in malaria parasites
- (2017) David A. Baker et al. Open Biology
- cGMP Binding Domain D Mediates a Unique Activation Mechanism in Plasmodium falciparum PKG
- (2017) Eugen Franz et al. ACS Infectious Diseases
- Oxidant sensor in the cGMP-binding pocket of PKGIα regulates nitroxyl-mediated kinase activity
- (2017) Sonia Donzelli et al. Scientific Reports
- New Pharmacological Strategies to Increase cGMP
- (2016) Alessia Buglioni et al. Annual Review of Medicine
- Erythrocytes do not activate purified and platelet soluble guanylate cyclases even in conditions favourable for NO synthesis
- (2016) Stepan Gambaryan et al. Cell Communication and Signaling
- Physiological Functions of NO-Sensitive Guanylyl Cyclase Isoforms
- (2016) Doris Koesling et al. CURRENT MEDICINAL CHEMISTRY
- Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
- (2016) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review
- (2016) Peter Sandner et al. GERONTOLOGY
- Iron deficiency anemia in cyclic GMP kinase knockout mice
- (2016) E. Angermeier et al. HAEMATOLOGICA
- Molecular Physiology of Membrane Guanylyl Cyclase Receptors
- (2016) Michaela Kuhn PHYSIOLOGICAL REVIEWS
- Iron deficiency anemia in cyclic GMP kinase knockout mice
- (2016) E. Angermeier et al. HAEMATOLOGICA
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial
- (2016) Gérald Simonneau et al. Lancet Respiratory Medicine
- cCMP and cUMP occur in vivo
- (2015) Heike Bähre et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis
- (2015) Tomoaki Higuchi et al. CLINICAL IMMUNOLOGY
- Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
- (2015) Lewis J. Rubin et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
- (2015) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
- (2015) Dong I. Lee et al. NATURE
- Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue
- (2015) Linda S. Hoffmann et al. Nature Communications
- Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells
- (2014) Heike Bähre et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Transgenic Mice for Real-Time Visualization of cGMP in Intact Adult Cardiomyocytes
- (2014) Konrad R. Götz et al. CIRCULATION RESEARCH
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defective nitric oxide metabolism in sickle cell disease
- (2014) Gregory J. Kato PEDIATRIC BLOOD & CANCER
- Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction
- (2013) Diana Bonderman et al. CIRCULATION
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice
- (2012) C. B. Almeida et al. BLOOD
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- A VASP-Rac-Soluble Guanylyl Cyclase Pathway Controls cGMP Production in Adipocytes
- (2012) K. Jennissen et al. Science Signaling
- Guanylyl cyclase structure, function and regulation
- (2011) Lincoln R. Potter CELLULAR SIGNALLING
- Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
- (2011) Sharron H. Francis et al. PHYSIOLOGICAL REVIEWS
- High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils
- (2008) Camila Bononi Almeida et al. BRITISH JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started